IMR Press / EJGO / Volume 19 / Issue 6 / pii/1998233

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Case Report

The relation between erythropoietin, hematocrit and hemoglobin in breast cancer patients on non-nephrotoxic chemotherapy

Show Less
1 Departments of Internal Medicine and Obstetrics and Gynecology1, American University of Beirut Medical Center, Beirut, Lebanon
Eur. J. Gynaecol. Oncol. 1998, 19(6), 577–579;
Published: 10 December 1998

Serum erythropoietin (EPO), hematocrit and hemoglobin levels were determined in 17 female patients with stage II breast cancer before, during and at the conclusion of non-nephrotoxic chemotherapy. Serum EPO levels were determined using the ELISA technique. No irradiation was given to any patient. The hemoglobin and hematocrit levels remained stable. However, a statistically significant increase in EPO was noted (p < 0.05). The possible factors involved in this increase are reviewed, however the exact mechanism remains to be elucidated.

Breast cancer
Back to top